Business Description

Compare
Compare
Traded in other countries / regions
IPO Date
2026-05-29
Description
Encore Medical Inc develops, manufactures, and markets septal occlusion devices for the repair of certain cardiac defects. Its products have been implanted in approximately 35,000 patients outside the United States. Its closure device is designed to correct a cardiac defect, generally diagnosed in adulthood, known as a patent foramen ovale (PFO). The company also currently market and sell septal occlusion devices for the transcatheter closure of atrial septal defects (ASD).

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

GF Valueâ„¢

Encore Medical Inc Filings

Filing Date Document Date Form
No Filing Data

Encore Medical Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Guru Commentaries on AMEX:EMI

No articles.

Press Release

Subject Date
No Press Release

Articles on Encore Medical Inc

No articles.

Headlines

See More
  • 1
No news.
  • 1